Objective To review published randomised controlled trials to assess the benefit and harm of
imiquimod in the treatment of external genital warts. Data sources MEDLINE (1966 …

Genital warts affect at least 1% of sexually active adults. Current therapies are inadequate
because they are often painful, may fail to prevent recurrence and transmission of warts, and …

Genital warts affect 1% of the sexually active US population and are commonly seen in
primary care. Human papillomavirus types 6 and 11 are responsible for most genital warts …

Genital warts are usually asymptomatic, and rarely cause discomfort. Once the patient is
aware of them the main symptom is their cosmetic appearance and resultant psychological …

Objective: The objective of this randomized, double-blind, placebo-controlled trial was to
evaluate the mechanism of action of imiquimod cream in the treatment of anogenital warts …

Genital human papillomavirus (HPV) infection is very common, and often sub-clinical and
usually resolves without any treatment. Genital warts are caused by HPV 6/11 infection and …

The time between exposure to HPV and development of EGWs can vary from a few weeks to
several months or years (median, 2.9 months). 9 Many HPV infections are mild and …

Cutaneous and genital warts are common dermatological conditions caused by the human
papilloma virus (HPV). Although it is a benign condition, it causes disfigurement, has a …

Genital warts (condyloma acuminatum, venereal warts) are common highly contagious
benign epithelial lesions occurring on the genitals, perianal area, and inguinal folds, and are …

BACKGROUND The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …